Sevelamer Carbonate (Verlaserv)

Indications:

Sevelamer Carbonate is indicated for the control of serum phosphorus in patient with chronic kidney disease (CKD) on dialysis. It is also indicated for the control of hyperphosphatemia in adult patient receiving hemodialysis or peritoneal dialysis. It is also approved for adult CKD patients not on dialysis with serum phosphorus >1.78 mmol/L.

Dosage and Administration:

Adults and Elderly (>65 years): Patients Not Taking a Phosphorus Binder: The recommended starting dose for patients not taking a phosphate binder is 800 to 1600 mg, which can be administered as one to two Sevelamer Carbonate 800 mg tablets with each meal based on serum phosphorus level.


Download Product Insert:

CLICK HERE